Middle East and Africa Non-Invasive Aesthetic Treatment Market

Market Introduction

Non-invasive or non-surgical aesthetic treatment refers to the aesthetic procedures that does not require any kind of surgical incision. Sometimes, minimally invasive surgeries are also considered as non-surgical procedures. Some of the commonly conducted non-invasive aesthetic treatment includes botulinum toxin injection, chemical peels, non-surgical laser treatment, and microdermabrasion amongst other.

Market Overview and Dynamics

The Middle East and Africa non-invasive aesthetic treatment market is expected to reach US$ 270.52 million by 2028 from US$ 151.37 million in 2021; it is estimated to grow at a CAGR of 8.6% from 2021 to 2028. The growth of the market is attributed to a few key driving factors such as surging awareness about cosmetic procedures among consumers, availability of technologically advanced products in aesthetics, and proliferating medical tourism. However, clinical risks and complications associated with medical aesthetic procedures are hindering the market growth.

Non-invasive aesthetic treatments have gained popularity in the past few years due to advantages such as minimal downtime, no scars, low cost, and less complications. The popularity and acceptance of these procedures is mainly attributed to their non-invasiveness. Besides, it has been proved that the accuracy rate of minimally invasive surgeries is greater than that of open surgeries. Moreover, non-invasive treatments are gaining traction due to high preference for less downtime post treatment. Several government initiatives are helping in creating awareness regarding non-invasive aesthetic procedures among people. Therefore, the growing awareness regarding non-invasive aesthetic treatment procedures is boosting the growth of the Middle East and Africa non-invasive aesthetic treatment market. Several manufacturers are working on advanced non-invasive aesthetic treatment products. In October 2020, Alma launched its latest Alma Hybrid platform, designed to explore multiple possibilities of using ablative, non-ablative, and thermal treatments, along with testing their synergistic impact, on skin rejuvenation and scar revision. Therefore, the availability of user-friendly, technologically advanced non-invasive aesthetic treatment products is fuelling the market growth.

Socio–economic condition in Middle East countries has been widely affected by the COVID–19 pandemic. In addition, the lockdown has hindered the non-emergency medical services in the region, which has somehow adversely affected the aesthetic sectors. Saudi Arabia and the UAE are emerging as aesthetic destinations in the region. However, they are dependent on the foreign nations for the resources; therefore, the aesthetic industry has faced a negative impact and is expected to experience the same in the following few years. This is likely to have negative influence on the non-invasive aesthetic treatment market during the forecast period.

Key Market Segments

The Middle East and Africa non-invasive aesthetic treatment market, based on procedure, is segmented into injectables, skin rejuvenation, and others. The injectables segment held the largest share of the market in 2020, and the market for the same segment is expected to grow at the fastest rate during the forecast period.

The Middle East and Africa non-invasive aesthetic treatment market, by end user, is segmented into hospitals, clinics and medical spas, and others. The hospitals segment held the largest share of the market in 2020. Also, the same segment is anticipated to register the highest CAGR in the market during the forecast period.

Major Sources and Companies Listed

A few of the primary and secondary sources associated with this report on the Middle East and Africa non-invasive aesthetic treatment market are the Emirates Conformity Assessment Scheme (SCAS), Emirates Standardization and Meteorological Authority (ESMA) and Dubai Health Authority (DHA).

Reasons to buy the report

• Determine prospective investment areas based on a detailed trend analysis of Middle East and Africa non-invasive aesthetic treatment market over the next years.
• Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
• Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
• Identify the major channels driving the Middle East and Africa non-invasive aesthetic treatment market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
• Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Middle East and Africa non-invasive aesthetic treatment market.

MIDDLE EAST AND AFRICA NON-INVASIVE AESTHETIC TREATMENT MARKET SEGMENTATION

By Procedure

• Injectables
  • Botulinum Toxin
  • Calcium Hydroxylapatite
  • Hyaluronic Acid
  • Polymer Filler
  • Collagen
• Skin Rejuvenation
  • Chemical Peel
  • Laser Skin Resurfacing
  • Photorejuvenation
• Others
  • Hair Removal
  • Nonsurgical Fat Reduction
  • Sclerotherapy
  • Cellulite Treatment

By End User

• Hospitals
• Clinics and Medical Spas
• Others

By Country

• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East and Africa

Company Profiles

• Galderma
• Alma Lasers
• Merz Pharma
• Bausch Health Companies Inc.
• Cutera Inc.
• AbbVie Inc.
• Candela Medical
• Johnson and Johnson Services, Inc.

Middle East and Africa Non-Invasive Aesthetic Treatment Market Strategic Insights

Middle East and Africa Non-Invasive Aesthetic Treatment Market Segmentation Analysis

Middle East and Africa Non-Invasive Aesthetic Treatment Market Report Highlights

Middle East and Africa Non-Invasive Aesthetic Treatment Report Scope

Middle East and Africa Non-Invasive Aesthetic Treatment Market Country and Regional Insights